Lu, Y., Jiang, X., Li, Y., Li, F., Zhao, M., Lin, Y., . . . Jiang, L. (2024). NL101 synergizes with the BCL-2 inhibitor venetoclax through PI3K-dependent suppression of c-Myc in acute myeloid leukaemia. Journal of Translational Medicine, 22(1), . https://doi.org/10.1186/s12967-024-05647-0
Chicago-referens (17:e uppl.)Lu, Ying, et al. "NL101 Synergizes with the BCL-2 Inhibitor Venetoclax Through PI3K-dependent Suppression of C-Myc in Acute Myeloid Leukaemia." Journal of Translational Medicine 22, no. 1 (2024). https://doi.org/10.1186/s12967-024-05647-0.
MLA-referens (9:e uppl.)Lu, Ying, et al. "NL101 Synergizes with the BCL-2 Inhibitor Venetoclax Through PI3K-dependent Suppression of C-Myc in Acute Myeloid Leukaemia." Journal of Translational Medicine, vol. 22, no. 1, 2024, https://doi.org/10.1186/s12967-024-05647-0.
